Alumis Inc. – Filings and Transcripts

NASDAQ: ALMS
Share price (9/29/26): $7.29
Market cap (9/29/26): $944 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 06/30/26 Q2

ended 03/31/26 Q1

ended 12/31/25 FY 2025

ended 09/30/25 Q3

ended 06/30/25 Q2

Prospectuses and Registrations Filter

Automatic shelf registration

Registration of securities for employees

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Shelf registration

Ownership Filter

Akkaraju Srinivas

Foresite Capital Fund VI LP

Bradley Mark Christopher

News Filter

Announces Topline Results From Envudeucitinib Phase 2b Trial in Systemic Lupus Erythematosus

Reports Second Quarter 2026 Financial Results and Highlights Recent Achievements

Envudeucitinib Long-Term Data Positioned to Set a New Standard for Plaque Psoriasis Treatment, Delivering Highest Reported PASI 100 Skin Clearance Among Oral Therapies

Shareholder Vote Results

Investor Presentation

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Definitive proxy

Other Filter

Scanned paper annual report submission

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Scanned paper annual report submission